Matches in Wikidata for { <http://www.wikidata.org/entity/Q90755542> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q90755542 description "article scientifique publié en 2018" @default.
- Q90755542 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q90755542 description "scientific article published on 03 August 2018" @default.
- Q90755542 description "wetenschappelijk artikel" @default.
- Q90755542 description "наукова стаття, опублікована в серпні 2018" @default.
- Q90755542 description "գիտական հոդված հրատարակված 2018 թվականի օգոստոսի 3-ին" @default.
- Q90755542 name "Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer" @default.
- Q90755542 name "Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer" @default.
- Q90755542 type Item @default.
- Q90755542 label "Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer" @default.
- Q90755542 label "Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer" @default.
- Q90755542 prefLabel "Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer" @default.
- Q90755542 prefLabel "Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer" @default.
- Q90755542 P1433 Q90755542-2BB11A9E-D5AA-47CB-A843-6FCDEC26E338 @default.
- Q90755542 P1476 Q90755542-2FCFB62D-9E3A-47D9-AB99-644FBB44C708 @default.
- Q90755542 P2093 Q90755542-2846FF34-90BB-4F8C-908D-7CF57A8FA812 @default.
- Q90755542 P2093 Q90755542-2D7C4FCA-F593-4138-90F7-E889C446B260 @default.
- Q90755542 P2093 Q90755542-311EBE5D-6E23-4A57-999B-46160707A300 @default.
- Q90755542 P2093 Q90755542-41E7D394-D13C-4816-B6A3-AEC2D0E9A3FC @default.
- Q90755542 P2093 Q90755542-6136B62A-1CFD-407E-86C3-7E19CA612A40 @default.
- Q90755542 P2093 Q90755542-74B4A6AF-18A0-4A24-BF25-4D2637043ED6 @default.
- Q90755542 P2093 Q90755542-CDF1C77A-31D4-4CFD-B145-2B56F1AC86AF @default.
- Q90755542 P2093 Q90755542-DF28F29F-0E69-43A2-A25A-6A48F73DE041 @default.
- Q90755542 P304 Q90755542-4160FCAA-9F6F-4BC4-BC3B-E53A9A53C965 @default.
- Q90755542 P31 Q90755542-11BF4898-A758-4E8E-89E5-EFDBF734BCDA @default.
- Q90755542 P356 Q90755542-EFD62F96-3AE4-45E2-9EDB-5B45EE32AE1D @default.
- Q90755542 P4510 Q90755542-6251AF85-5F40-4FD8-AC9B-94164F7F9A51 @default.
- Q90755542 P478 Q90755542-B30C1A9A-5465-4DE6-AC86-63261F127FDD @default.
- Q90755542 P577 Q90755542-95D6B44C-8A84-4277-A500-D0142F935BE3 @default.
- Q90755542 P698 Q90755542-6A061AC9-7FDB-4F45-9040-E296388F346F @default.
- Q90755542 P932 Q90755542-E27019C0-6898-4820-9BC4-EFE3402023D5 @default.
- Q90755542 P356 J.CANLET.2018.07.039 @default.
- Q90755542 P698 30077739 @default.
- Q90755542 P1433 Q326372 @default.
- Q90755542 P1476 "Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer" @default.
- Q90755542 P2093 "Cherng-Chyi Tzeng" @default.
- Q90755542 P2093 "Dannah R Miller" @default.
- Q90755542 P2093 "Evan T Keller" @default.
- Q90755542 P2093 "Ming-Fong Lin" @default.
- Q90755542 P2093 "Steve Caplan" @default.
- Q90755542 P2093 "Trey Farmer" @default.
- Q90755542 P2093 "Yeh-Long Chen" @default.
- Q90755542 P2093 "Yu-Shuin Chen" @default.
- Q90755542 P304 "96-108" @default.
- Q90755542 P31 Q13442814 @default.
- Q90755542 P356 "10.1016/J.CANLET.2018.07.039" @default.
- Q90755542 P4510 Q1659584 @default.
- Q90755542 P478 "436" @default.
- Q90755542 P577 "2018-08-03T00:00:00Z" @default.
- Q90755542 P698 "30077739" @default.
- Q90755542 P932 "6278836" @default.